186648-63-5

Upstream product

• 51-21-8 5-fluorouracil 
• 166411-46-7 5-O-benzoyl-1-bromo-2,3-dideoxy-2-fluoro-α-L-threo-pentofuranosyl 
• 166411-42-3 1,2-O-isopropylidene-3-deoxy-3-(p-toluenesulfonylhydrazino)-5-O-benzoyl-α-L-ribofuranose 
• 166411-41-2 5-O-benzoyl-1,2-O-isopropylidene-p-toluenesulfonylhydrazone-α-L-erythro-pentofurano-3-ulose 
• 166411-45-6 5-O-benzoyl-2,3-dideoxy-1,2-difluoro-α-L-threo-pentofuranosyl 
• 166411-43-4 5-O-benzoyl-3-deoxy-1,2-O-isopropylidene-α-L-erythro-pentofuranose 
• 166411-40-1 5-O-benzoyl-1,2-O-isopropylidene-α-L-erythro-pentofuranose-3-ulose 

Relevant academic research and scientific papers

Synthesis of 2',3'-dideoxy-2'-fluoro-L-threo-pentofuranosyl nucleosides as potential antiviral agents

A series of 2',3'-dideoxy-2'-fluoro-L-threo-pentofuranosyl nucleosides has been synthesized as potential antiviral agents. The synthesized compounds were evaluated against HIV-1, HBV, HSV-1, and HSV-2. Among the synthesized analogues, only the cytosine derivative showed moderate antiviral activity against HIV and HBV.